The 5-minute Apgar score as a predictor of childhood cancer: A population-based cohort study in five million children

BMJ Open

Volumn 2, Issue 4, 2012, Pages

  Li, Jiong ^a   Cnattingus, Sven ^b   Gissler, Mika ^c,d   Vestergaard, Mogens ^a   Obel, Carsten ^a   Ahrensberg, Jette ^a   Olsen, Jørn ^a,e  

^a AARHUS UNIVERSITY   (Denmark)

^b KAROLINSKA INSTITUTE   (Sweden)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; APGAR SCORE; ARTICLE; BIRTH; CANCER DIAGNOSIS; CANCER RISK; CHILD; CHILDHOOD CANCER; FEMALE; FOLLOW UP; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; POPULATION BASED CASE CONTROL STUDY; PREDICTIVE VALUE; PRESCHOOL CHILD; SCHOOL CHILD;

EID: 84865136289     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-001095     Document Type: Article

References (46)

1. Kaatsch P. Epidemiology of childhood cancer. Cancer Treat Rev 2010;36:277-85.
2. Parkin DM, Whelan S, Ferlay J, et al. Cancer incidence in five continents VIII . Lyon, France: IARC Scientific Publications, 2002.
3. Anderson LM. Environmental genotoxicants/carcinogens and childhood cancer: bridgeable gaps in scientific knowledge. Mutat Res 2006;608:136-56.
4. Kimmel GL. An overview of children as a special population - relevance to predictive biomarkers. Toxicol Appl Pharmacol 2005;206:215-18.
5. Garner MJ, Turner MC, Ghadirian P, et al. Epidemiology of testicular cancer: an overview. Int J Cancer 2005;116:331-9.
6. Greaves M. Molecular genetics, natural history and the demise of childhood leukaemia. Eur J Cancer 1999;35:1941-53.
7. Ma X, Metayer C, Does MB, et al. Maternal pregnancy loss, birth characteristics, and childhood leukemia (United States). Cancer Causes Control 2005;16:1075-83.
8. Tower RL, Spector LG. The epidemiology of childhood leukemia with a focus on birth weight and diet. Crit Rev Clin Lab Sci 2007;44:203-42.
9. Von Behren J, Spector LG, Mueller BA, et al. Birth order and risk of childhood cancer: a pooled analysis from five US States. Int J Cancer 2011;128:2709-16.
10. Apgar V. A proposal for a new method of evaluation of the newborn infant. Curr Res Anesth Analg 1953;32:260-7.
11. Use and abuse of the Apgar score. Committee on Fetus and Newborn, American Academy of Pediatrics, and Committee on Obstetric Practice, American College of Obstetricians and Gynecologists. Pediatrics 1996;98:141-2.
12. Finster MMD, Wood MMD. The Apgar score has survived the test of time. Anesthesiology 2005;102:855-7.
13. Papile LA. The Apgar score in the 21st century. N Engl J Med 2001;344:519-20.
14. Casey BM, McIntire DD, Leveno KJ. The continuing value of the Apgar score for the assessment of newborn infants. N Engl J Med 2001;344:467-71.
15. Li J, Olsen J, Vestergaard M, et al. Low Apgar scores and risk of childhood attention deficit hyperactivity disorder. J Pediatr 2011;158:775-9.
16. Moster D, Lie RT, Irgens LM, et al. The association of Apgar score with subsequent death and cerebral palsy: a population-based study in term infants. J Pediatrics 2001;138:798-803.
17. Odd DE, Rasmussen F, Gunnell D, et al. A cohort study of low Apgar scores and cognitive outcomes. Arch Dis Child Fetal Neonatal Ed 2008;93:F115-20.
18. Stuart A, Olausson PO, Kallen K. Apgar scores at 5 minutes after birth in relation to school performance at 16 years of age. Obstet Gynecol 2011;118:201-8.
19. Sun Y, Vestergaard M, Pedersen CB, et al. Apgar scores and long-term risk of epilepsy. Epidemiology 2006;17:296-301.
20. Gilstrap LC III, Hauth JC, Hankins GD, et al. Second-stage fetal heart rate abnormalities and type of neonatal acidemia. Obstet Gynecol 1987;70:191-5.
21. Ekbom A. The developmental environment and the early origins of cancer. In: Gluckman P, Hanson M. eds. Developmental origins of health and disease. Cambridge: Cambridge University Press, 2006:415-25.
22. Gluckman PD, Hanson MA. Living with the past: evolution, development, and patterns of disease. Science 2004;305:1733-6.
23. Gluckman PD, Hanson MA, Cooper C, et al. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008;359:61-73.
24. Greaves M. Childhood leukaemia. BMJ 2002;324:283-7.
25. Okasha M, McCarron P, Gunnell D, et al. Exposures in childhood, adolescence and early adulthood and breast cancer risk: a systematic review of the literature. Breast Cancer Res Treat 2003;78:223-76.
26. Park SK, Kang D, McGlynn KA, et al. Intrauterine environments and breast cancer risk: meta-analysis and systematic review. Breast Cancer Res 2008;10:R8.
27. Frank L. Epidemiology. When an entire country is a cohort. Science 2000;287:2398-9.
28. Li J, Vestergaard M, Obel C, et al. Cohort profile: the nordic perinatal bereavement cohort. Int J Epidemiol 2010;40:1161-7.
29. Knudsen LB, Olsen J. The Danish medical birth registry. Dan Med Bull 1998;45:320-3.
30. Axelsson O. The Swedish medical birth register. Acta Obstet Gynecol Scand 2003;82:491-2.
31. Barlow L, Westergren K, Holmberg L, et al. The completeness of the Swedish Cancer Register ΓÇô a sample survey for year 1998. Acta Oncol 2009;48:27-33.
32. Gjerstorff ML. The Danish cancer registry. Scand J Public Health 2011;39:42-5.
33. Petridou E, Panagiotopoulou K, Katsouyanni K, et al. Tobacco smoking, pregnancy estrogens, and birth weight. Epidemiology 1990;1:247-50.
34. Liehr JG. Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev 2000;21:40-54.
35. Law GR. Host, family and community proxies for infections potentially associated with leukaemia. Radiat Prot Dosimetry 2008;132:267-72.
36. Sadetzki S, Mandelzweig L. Childhood exposure to external ionising radiation and solid cancer risk. Br J Cancer 2009;100:1021-5.
37. Spector LG, Klebanoff MA, Feusner JH, et al. Childhood cancer following neonatal oxygen supplementation. J Pediatr 2005;147:27-31.
38. Greaves M. Molecular genetics, natural history and the demise of childhood leukaemia. Eur J Cancer 1999;35:173-85.
39. Heuch JM, Heuch I, Kvale G. Birth characteristics and risk of Wilms' tumour: a nationwide prospective study in Norway. Br J Cancer 1996;74:1148-51.
40. Schuz J, Schmidt LS, Kogner P, et al. Birth characteristics and Wilms tumors in children in the Nordic countries: a register-based case-control study. Int J Cancer 2011;128:2166-73.
41. Puumala SE, Soler JT, Johnson KJ, et al. Birth characteristics and Wilms tumor in Minnesota. Int J Cancer 2008;122:1368-73.
42. Ruan K, Song G, Ouyang G. Role of hypoxia in the hallmarks of human cancer. J Cell Biochem 2009;107:1053-62.
43. Rankin EB, Giaccia AJ. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 2008;15:678-85.
44. Reynolds P, Urayama KY, Von Behren J, et al. Birth characteristics and hepatoblastoma risk in young children. Cancer 2004;100:1070-6.
45. McLaughlin CC, Baptiste MS, Schymura MJ, et al. Maternal and infant birth characteristics and hepatoblastoma. Am J Epidemiol 2006;163:818-28.
46. Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd edn. Philadelphia: Lippincott Williams & Wilkins, 2008.